| Trial ID: | L0168 |
| Source ID: | NCT02299310
|
| Associated Drug: |
Valsartan
|
| Title: |
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Valsartan|DRUG: Perindopril
|
| Outcome Measures: |
Primary: Homeostasis model of assessment for insulin resistence index (HOMA-IR index), HOMA-IR=FINS\*FGLU/22.5, 4 weeks | Secondary: Glomerular filtration rate(eGFR) and Creatinine clearance rate(CCR), eGFR and CCR are calculated with MDRD formula, 4 weeks|Body mass index(BMI), BMI=weight/(height)\^2, 4 weeks|24-h urine protein, urinary albumin-creatinin ration, retinol binding protein, 4 weeks|Cholesterol, triglycerides, high density lipoprotein, low density lipoprotein, 4 weeks|Glycosylated hemoglobin, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: Chinese PLA General Hospital
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-11
|
| Completion Date: |
2015-12
|
| Results First Posted: |
|
| Last Update Posted: |
2014-12-02
|
| Locations: |
Chinese PLA General Hospital, Beijing, Beijing, 100853, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02299310
|
